Search references for TRONTINEMAB. Phrases containing TRONTINEMAB
See searches and references containing TRONTINEMAB!TRONTINEMAB
Monoclonal antibody
Trontinemab (RG6102) is a monoclonal antibody (mAb) developed by Roche/Genentech for the treatment of Alzheimer's disease. It is based on gantenerumab
Trontinemab
Technology assisting antibody uptake
It has been tested with anti-amyloid monoclonal antibodies such as trontinemab. The formulation reported in a 2013 paper by Niewoehner et al. used a
Brainshuttle
Monoclonal antibody protein
Gantenerumab has been further developed into trontinemab, which started a Phase III trial in 2025. Trontinemab consists of gantenerumab fused to Roche's
Gantenerumab
TRONTINEMAB
TRONTINEMAB
TRONTINEMAB
TRONTINEMAB
TRONTINEMAB
TRONTINEMAB
TRONTINEMAB
TRONTINEMAB
TRONTINEMAB